SCHULMAN AMY W 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Mar 14, 2025
Insider Transaction Report
Form 4
SCHULMAN AMY W
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-13$131.21/sh+2,750$360,828→ 11,186 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-13−2,750→ 0 totalExercise: $131.21From: 2016-06-01Exp: 2025-06-01→ Common Stock (2,750 underlying)
Footnotes (2)
- [F1]The options exercised and held by the reporting person were due to expire on June 1, 2025.
- [F2]The stock option was fully vested as of June 1, 2016.